MedPath

POTASSIUM ACETATE INJECTION USP

POTASSIUM ACETATE INJECTION USP

Approved
DIN Number

02362597

Drug Class

Human

Market Date

Jul 18, 2016

Company
HC

omega laboratories limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02362597
AIG Number0107304002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
B05XA17 POTASSIUM ACETATE
Product Specifications
Dosage FormLiquid
Route of AdministrationIntravenous
AHFS Classification40:12.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

POTASSIUM ACETATEActive
Strength: 39.2 % / W/V
Monograph: POTASSIUM ACETATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.